Autism can now be treated with HESC Therapy
New Delhi: A three-year-old boy having Autism Spectrum Disorder (ASD) was treated with hESC therapy. ASD is a neuro-developmental disorder which is accompanied by weak immune system, neuro inflammation and is characterized by social disconnection, incomplete verbal and nonverbal communication, severely restricted interests, and display of repetitive obsessive behaviours.
“He wasadmitted to NuTech Mediworld by his parents with complaints of poor attention,lack of eye contact, no social interaction, shivery hands, inability to pointat objects, lack of functional independence and inability to speak clearly.Patient’s medical history revealed ASD. He was undergoing speech andoccupational therapy with no noticeable progression. We investigated his brainusing SPECT scan that revealed a peripheral circulatory failure known ashypoperfusion. It happens due to loss of circulating fluids.”
People withASD have delayed metabolism and Vitamin D deficiency. Multiple factorscontribute to ASD including transfer of maternal antibodies, infection inmaternal blood, and exposure to heavy metals, prenatal folic acid deficiency,genetic disorders, measles, and electromagnetic radiation. These factors put anegative impact on CNS, neurodevelopment. Though it cannot be cured completely,treatment through hESC provides quality of life.
As thecondition was getting severe hESC therapy was started, to be conducted in 4sessions along with occupational and physical therapy. After each session,SPECT scan was done in order to keep a check on the hypoperfusion.
“The patientshowed significant improvements in eye contact, social behaviours, and speechand was able to follow basic commands becoming more independent functionallyand showed improvements in vocabulary, social awareness and became emotionallyattached to his parents after the 2nd session. The SPECT scanalso showed minimal hypoperfusion with significant improvements in the affectedregions of the brain. The second and the third phase are utilized to add morecells into the body, to aid maximum repair and regeneration without any adverseevent.”
Humanembryonic stem cells (hESC) are pluripotent, can proliferate indefinitely, andcan differentiate into all cell types. This provides an underlying principlefor using hESC therapy in ASD. Improvement is also seen in patients withcerebral palsy and cortical visual impairment after treatment with hESCtherapy. Stem cell therapy is showing promise in the treatment of incurablediseases.
“Followingthe 3rd session of the treatment, improvement was seen in hisexpressions, duration of attention as well. hESC treatment helped the boy tosubside autism by improving blood perfusion in his brain, improve motor, socialand cognition skills as well. The use of human embryonic stem cell therapy is asafe and effective treatment for patients with autism spectrum disorder.”
Dr Shroff,who has treated almost 1500 patients so far with no side effects, has over 40research papers published in reputed journals in different parts of the world.She has multiple patents in over 65 countries, including the US, Singapore,Japan, Australia and New Zealand, regarding the technology and its therapeuticapplication.
hESC therapyis followed by SPECT scan to observe the significant improvements in the bloodperfusion with the use of nuclear imaging. It is a test used to examine thefunctioning of organs and the extent of blood perfusion in the brain. Thistherapy has been effective in improving motor skills, social skills, andcognition in patients with autism spectrum disorder.